CarolinasDentist Fuquay-Varina Office Celebrates its Five-Year Anniversary
The Fuquay-Varina practice invites the community to join its celebration of the milestone eventFUQUAY-VARINA, N.C., Nov. 16, 2021 (GLOBE NEWSWIRE)...
Year: 2021
Juno College of Technology Student Awarded with eSight device
Jaclyn Pope to use advanced vision technology to complete full stack development programTORONTO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- A...
PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats
Robust SARS-CoV-2 sequencing kit and upgraded microbial whole genome assembly workflow enable public health laboratories to scale pathogen surveillance programsMENLO...
AXIM Biotechnologies Partners with Arizona State University to Determine Antibody Levels Against COVID-19
Company develops COVID-19 “Correlate of Protection” research to measure levels of neutralizing antibodies which protect from infectionSAN DIEGO, Nov. 16,...
Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer
Experienced Clinical Executive to Lead Patient and Caregiver ExperiencesKANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ:...
Morphic Announces Participation in Upcoming Investor Conferences
WALTHAM, Mass., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral...
Origin Therapeutics Announces Leadership Team
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Origin Therapeutics Holdings Inc. (the “Company” or “Origin Therapeutics”), an actively...
Allied Corp Progresses Towards Clinical Phase I Trial for Psilonex™ RX Psilocybin Pharma Drug
KELOWNA, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer Study
EDISON, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial...
European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat
- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications - NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) --...
Rakovina Therapeutics Partners with St. Baldrick’s Foundation to Research and Develop New Treatments for Childhood Bone Cancer
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) ("the Company"), a biopharmaceutical company committed...
Fluidigm to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision...
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical Trial of the First Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes
-Initiation of patient enrollment expected by year-end--Initiation of patient enrollment expected by year-end- ZUG, Switzerland and CAMBRIDGE, Mass. and SAN...
VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to...
Oncotelic Announces Successful Completion of the Safety Evaluation of a TGF-β Inhibitor (OT-101) and IL-2 (Aldesleukin) in Phase 1 Combination Trial in Solid Tumor Cancers
AGOURA HILLS, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer...
Optinose Announces Pricing of Public Offering of Common Stock
YARDLEY, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose...
Abyssinia Biologics Debuts Data on Ultra-sensitive Plasma Immunoassay for Key Synaptotoxin in Alzheimer’s Disease Pathogenesis
Assay developed using Abyssinia proprietary antibodies shows promise as sensitive and specific companion diagnosticFurther pre-clinical data hints at potential therapeutic...
Adventist Health Selects R1 as Patient Billing Partner in its Quest for Consumer Excellence
VisitPay to offer a seamless and complete payment experience for Adventist Health patients expanding the reach of R1’s Entri™ platformMURRAY,...
AGTC Appoints Abraham Scaria, Ph.D., as Chief Science Officer
With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early research into clinical development Dr. Scaria...
Coya Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA on COYA101 for the Treatment of Amyotrophic Lateral Sclerosis
Plans to submit an IND to support a Phase 2b clinical trial for COYA101HOUSTON, Nov. 16, 2021 (GLOBE NEWSWIRE) --...
